Appeal Dismissed: Tribunal Upholds Rulings on Share Expenses, Business Deductions, and More Under Relevant Tax Sections.

The appeal was dismissed, with the Tribunal's rulings upheld on all issues. These included the capitalization of share issue expenses, allowance of consumables as business expenditure, treatment of interest on DPEA liability, taxation of advance license receivable, and deductions under Sections 80M, 80I/80IA, and 80IB. The Tribunal's decisions were supported by prior judgments favoring the respondent assessee, leading to the rejection of all questions raised by the Revenue. Payments to Glaxo Sports Club were deemed not applicable under Section 40A(9), and the allocation of administrative expenses was directed not to be attributed to Nasik Units.

---

---

Issues involved:
1. Capitalization of share issue expenses for purchase of plant and machinery
2. Allowance of entire expenditure on consumables as business expenditure
3. Treatment of interest on DPEA liability as expenditure
4. Taxation of advance license receivable
5. Allowance of deduction u/s 80M on entire dividend income
6. Estimation of expenses attributable to exempt income for deduction u/s 80M
7. Applicability of Section 40A(9) on payments made to Glaxo Sports Club
8. Allocation of Head Office Administrative Expenses and interest cost for deduction under Section 80I/80IA
9. Disallowances made by Assessing Officer for deduction u/s 80IB and 80IB

Analysis:
1. The appeal challenged the Tribunal's order on various issues, including the capitalization of share issue expenses for purchasing plant and machinery. The Counsel for the Revenue acknowledged that previous decisions favored the respondent assessee, leading to the dismissal of this question.
2. Similarly, the Tribunal's decision on allowing the entire expenditure on consumables as business expenditure was upheld based on past judgments in favor of the respondent assessee for the relevant assessment year.
3. The treatment of interest on DPEA liability as expenditure was also settled in favor of the respondent assessee through previous rulings, resulting in the dismissal of this question.
4. The taxation of advance license receivable was determined based on the timing of benefits accrual, aligning with past decisions and leading to the rejection of this question.
5. The allowance of deduction u/s 80M on the entire dividend income received was supported by previous judgments, resulting in the dismissal of this question.
6. The estimation of expenses attributable to exempt income for deduction u/s 80M was addressed based on the common P&L account maintained by the assessee, leading to the rejection of this question.
7. The Tribunal's decision on payments made to Glaxo Sports Club not falling under Section 40A(9) was upheld, resulting in the dismissal of this question.
8. Regarding the allocation of Head Office Administrative Expenses and interest cost for deduction under Section 80I/80IA, the Tribunal's direction to not allocate these expenses to Nasik Units was supported by past decisions, leading to the rejection of this question.
9. The Tribunal's direction to consider disallowances made by the Assessing Officer as part of the profit of the eligible unit for the purpose of deduction u/s 80IB and 80IB was upheld based on previous rulings, resulting in the dismissal of this question. The appeal was ultimately dismissed, acknowledging the efforts made by the Principal Commissioner of Income Tax and the Counsel for the Revenue in presenting relevant information.

---